Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce R Schackman

Showing results (171-180 of 222) with videos related to

Pageof 23
Sort By:
Addiction (Abingdon, England)|November 26, 2021
Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode IslandShayla Nolen, Xiao Zang, Avik Chatterjee, et al.
The Journal of Infectious Diseases|February 14, 2008
Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjectsDaniel R Kuritzkes, Christina M Lalama, Heather J Ribaudo, et al.
Journal of Public Health Management and Practice : JPHMP|July 6, 2018
A Cost Reimbursement Model for Hepatitis C Treatment Care CoordinationCzarina N Behrends, Ashley A Eggman, Sarah Gutkind, et al.
Implementation Science : IS|June 16, 2019
Improving HIV service delivery for people who inject drugs in Kazakhstan: study protocol for the Bridge stepped-wedge trialTara McCrimmon, Louisa Gilbert, Timothy Hunt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2009
Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapyElena Losina, Bruce R Schackman, Sara N Sadownik, et al.
JAMA Network Open|November 9, 2022
Comparing Projected Fatal Overdose Outcomes and Costs of Strategies to Expand Community-Based Distribution of Naloxone in Rhode IslandXiao Zang, Sam E Bessey, Maxwell S Krieger, et al.
JAMA Network Open|May 30, 2024
Evaluation of Strategies to Enhance Community-Based Naloxone Distribution Supported by an Opioid SettlementXiao Zang, Alexandra Skinner, Maxwell S Krieger, et al.
HIV Clinical Trials|December 15, 2015
Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the USPamela P Pei, Milton C Weinstein, X Cynthia Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care SettingsSabrina A Assoumou, Abriana Tasillo, Jared A Leff, et al.
Drug and Alcohol Dependence|November 13, 2016
Substance use and STI acquisition: Secondary analysis from the AWARE studyDaniel J Feaster, Carrigan L Parish, Lauren Gooden, et al.
Pageof 23

Showing results (171-180 of 222) with videos related to

Sort By:
Pageof 23
Addiction (Abingdon, England)|November 26, 2021
Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode IslandShayla Nolen, Xiao Zang, Avik Chatterjee, et al.
The Journal of Infectious Diseases|February 14, 2008
Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjectsDaniel R Kuritzkes, Christina M Lalama, Heather J Ribaudo, et al.
Journal of Public Health Management and Practice : JPHMP|July 6, 2018
A Cost Reimbursement Model for Hepatitis C Treatment Care CoordinationCzarina N Behrends, Ashley A Eggman, Sarah Gutkind, et al.
Implementation Science : IS|June 16, 2019
Improving HIV service delivery for people who inject drugs in Kazakhstan: study protocol for the Bridge stepped-wedge trialTara McCrimmon, Louisa Gilbert, Timothy Hunt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2009
Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapyElena Losina, Bruce R Schackman, Sara N Sadownik, et al.
JAMA Network Open|November 9, 2022
Comparing Projected Fatal Overdose Outcomes and Costs of Strategies to Expand Community-Based Distribution of Naloxone in Rhode IslandXiao Zang, Sam E Bessey, Maxwell S Krieger, et al.
JAMA Network Open|May 30, 2024
Evaluation of Strategies to Enhance Community-Based Naloxone Distribution Supported by an Opioid SettlementXiao Zang, Alexandra Skinner, Maxwell S Krieger, et al.
HIV Clinical Trials|December 15, 2015
Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the USPamela P Pei, Milton C Weinstein, X Cynthia Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care SettingsSabrina A Assoumou, Abriana Tasillo, Jared A Leff, et al.
Drug and Alcohol Dependence|November 13, 2016
Substance use and STI acquisition: Secondary analysis from the AWARE studyDaniel J Feaster, Carrigan L Parish, Lauren Gooden, et al.
Pageof 23